Prescient Therapeutics Limited (ASX:PTX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0420
-0.0010 (-2.33%)
Aug 26, 2025, 11:39 AM AEST

Prescient Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
Net Income
-7.32-8.24-7-5.12-4.15
Upgrade
Depreciation & Amortization
-0.010000
Upgrade
Asset Writedown & Restructuring Costs
-1.72---
Upgrade
Stock-Based Compensation
0.350.210.460.880.65
Upgrade
Other Operating Activities
0.010.020.01-0.060.04
Upgrade
Change in Accounts Receivable
-0.050-0.13-0.02-0.02
Upgrade
Change in Accounts Payable
0.09-0.061.160.39-0.39
Upgrade
Change in Other Net Operating Assets
-0.31-1.06-0.69-0.39-0.1
Upgrade
Operating Cash Flow
-7.24-7.4-6.19-4.31-3.97
Upgrade
Capital Expenditures
----0-0
Upgrade
Investment in Securities
412-16--
Upgrade
Investing Cash Flow
412-16-0-0
Upgrade
Short-Term Debt Issued
----0.01
Upgrade
Long-Term Debt Issued
-0.02---
Upgrade
Total Debt Issued
-0.02--0.01
Upgrade
Short-Term Debt Repaid
----0.17-
Upgrade
Long-Term Debt Repaid
-0.33----
Upgrade
Total Debt Repaid
-0.33---0.17-
Upgrade
Net Debt Issued (Repaid)
-0.330.02--0.170.01
Upgrade
Issuance of Common Stock
--16.530.5913.58
Upgrade
Other Financing Activities
---0.7--0.84
Upgrade
Financing Cash Flow
-0.330.0215.830.4312.75
Upgrade
Foreign Exchange Rate Adjustments
-0.01-0.02-0.010.06-0.04
Upgrade
Net Cash Flow
-3.594.6-6.37-3.838.74
Upgrade
Free Cash Flow
-7.24-7.4-6.19-4.32-3.97
Upgrade
Free Cash Flow Margin
-166.27%-199.28%-254.97%-228.50%-335.08%
Upgrade
Free Cash Flow Per Share
-0.01-0.01-0.01-0.01-0.01
Upgrade
Cash Income Tax Paid
-3.71-2.37-1.64-1.3-1.03
Upgrade
Levered Free Cash Flow
-4.94-5.72-3.84-2.4-2.52
Upgrade
Unlevered Free Cash Flow
-4.94-5.72-3.84-2.4-2.52
Upgrade
Change in Working Capital
-0.28-1.110.34-0.03-0.51
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.